The presence of HPV DNA in cervical cancer: Correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University-Reference-Cited by-同舟云学术

The presence of HPV DNA in cervical cancer: Correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University

Published:2001-01-26 Issue:1 Volume:11 Page:39-48
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:Int J Gynecol Cancer

Author:

Pilch H.,Gunzel S.,Schaffer U.,Tanner B.,Brockerhoff P.,Maeurer M.,Hockel M.,Hommel G.,Knapstein P. G.

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference36 articles.

1. Die Bewertung prognostischer Kriterien bei Karzinomen des Uterus

2. A review of prognostic factors in early-stage carcinoma of the cervix (FIGO I B and II A) and implications for treatment strategy

3. Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Status and molecular genetic parameters of papillomavirus infection: individual characteristics and associative links with clinical and morphological factors of cervical cancer;South Russian Journal of Cancer;2024-05-28

2. Impact of Human Papillomavirus (HPV) Infection on the Treatment Outcome of Concomitant Chemoradiotherapy (CRT) in Cervical Cancer;Current Cancer Therapy Reviews;2024-05

3. Topics of Histopathology and Cytology of Cervical Cancer and Screening;Comprehensive Gynecology and Obstetrics;2024

4. Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions;Advances in Anatomic Pathology;2023-08-28

5. Current Methods and Advances in the Immunotherapy Treatment of Non-Ovarian Gynaecological Cancers;Future Pharmacology;2023-06-01